Plains All Amern Pipeline L (PAA) Share Value Rose While Salient Trust Company Lta Has Increased by $606,579 Its Position; Chemocentryx (CCXI) Holder Geode Capital Management Has Decreased Its Position by $348,790



November 15, 2018 – By Ricky Cave

ChemoCentryx, Inc. (NASDAQ:CCXI) Logo

Salient Trust Company Lta increased its stake in Plains All Amern Pipeline L (PAA) by 69.88% based on its latest 2018Q2 regulatory filing with the SEC. Salient Trust Company Lta bought 26,373 shares as the company’s stock rose 1.15% with the market. The institutional investor held 64,111 shares of the energy company at the end of 2018Q2, valued at $1.52 million, up from 37,738 at the end of the previous reported quarter. Salient Trust Company Lta who had been investing in Plains All Amern Pipeline L for a number of months, seems to be bullish on the $16.23B market cap company. The stock increased 1.09% or $0.24 during the last trading session, reaching $22.34. About 208,250 shares traded. Plains All American Pipeline, L.P. (NYSE:PAA) has risen 15.74% since November 15, 2017 and is uptrending. It has outperformed by 0.12% the S&P500.

Geode Capital Management Llc decreased its stake in Chemocentryx Inc (CCXI) by 10.34% based on its latest 2018Q2 regulatory filing with the SEC. Geode Capital Management Llc sold 26,830 shares as the company’s stock declined 9.17% while stock markets rallied. The institutional investor held 232,728 shares of the health care company at the end of 2018Q2, valued at $3.06 million, down from 259,558 at the end of the previous reported quarter. Geode Capital Management Llc who had been investing in Chemocentryx Inc for a number of months, seems to be less bullish one the $471.41M market cap company. The stock increased 1.97% or $0.18 during the last trading session, reaching $9.33. About 17,753 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 51.30% since November 15, 2017 and is uptrending. It has outperformed by 35.68% the S&P500. Some Historical CCXI News: 09/03/2018 – CHEMOCENTRYX INC QUARTERLY SHR $0.80; 09/03/2018 – ChemoCentryx Expects to Utilize Between $65M-$75M Cash and Investments in FY18; 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; 09/03/2018 – CCXI TO BEGIN AVACOPAN CLINICAL STUDIES IN HS BY ’18 END; 20/04/2018 – DJ Chemocentryx Inc, Inst Holders, 1Q 2018 (CCXI); 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 09/03/2018 – ChemoCentryx 4Q Net $39.7M; 09/05/2018 – CHEMOCENTRYX INC – QTRLY DILUTED NET LOSS PER COMMON SHARE $0.19; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS)

Investors sentiment increased to 1.59 in Q2 2018. Its up 0.59, from 1 in 2018Q1. It is positive, as 11 investors sold CCXI shares while 28 reduced holdings. 28 funds opened positions while 34 raised stakes. 26.37 million shares or 8.85% more from 24.22 million shares in 2018Q1 were reported. Voya Management Ltd Com holds 0% or 10,588 shares in its portfolio. Daiwa Securities holds 0% in ChemoCentryx, Inc. (NASDAQ:CCXI) or 269 shares. Adams Diversified Equity Fund invested 0.03% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Parametric Portfolio Associates Limited Liability Company invested 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Royal Bank Of Canada holds 0% or 12 shares. Bvf Il holds 9.04% or 7.03 million shares in its portfolio. Paloma Management accumulated 12,100 shares or 0% of the stock. Public Employees Retirement Of Ohio invested 0.01% in ChemoCentryx, Inc. (NASDAQ:CCXI). Deutsche National Bank & Trust Ag has 76,598 shares for 0% of their portfolio. Swiss Fincl Bank holds 0% or 38,400 shares. Jpmorgan Chase & accumulated 0% or 197,230 shares. Trexquant Invest Limited Partnership holds 17,056 shares or 0.02% of its portfolio. New Jersey-based Jacobs Levy Equity Mgmt has invested 0.01% in ChemoCentryx, Inc. (NASDAQ:CCXI). 74 were accumulated by Pnc Financial Ser Group Incorporated. Meeder Asset Mgmt Incorporated reported 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI).

Since May 15, 2018, it had 0 insider purchases, and 9 selling transactions for $89.33 million activity. KANAYA SUSAN M had sold 100 shares worth $1,410 on Friday, June 29. On Friday, October 26 the insider Cappel Markus J. sold $332,779. GLAXOSMITHKLINE PLC also sold $85.85 million worth of ChemoCentryx, Inc. (NASDAQ:CCXI) shares.

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Globenewswire.com which released: “ChemoCentryx Reports Third Quarter 2018 Financial Results and Recent Highlights” on November 08, 2018, also Benzinga.com with their article: “85 Biggest Movers From Friday” published on November 12, 2018, Seekingalpha.com published: “ChemoCentryx 2018 Q3 – Results – Earnings Call Slides” on November 08, 2018. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Seekingalpha.com and their article: “ChemoCentryx (CCXI) CEO Thomas Schall on Q3 2018 Results – Earnings Call Transcript” published on November 09, 2018 as well as Streetinsider.com‘s news article titled: “Baker Bros. Advisors 13F for Quarter Ended Sept. 30, 2018” with publication date: November 14, 2018.

Geode Capital Management Llc, which manages about $325.29 billion US Long portfolio, upped its stake in Hope Bancorp Inc by 121,730 shares to 1.33 million shares, valued at $23.64M in 2018Q2, according to the filing. It also increased its holding in Granite Point Mortgage Trust by 23,062 shares in the quarter, for a total of 400,067 shares, and has risen its stake in Heritage Commerce Corp (NASDAQ:HTBK).

Among 8 analysts covering ChemoCentryx (NASDAQ:CCXI), 4 have Buy rating, 1 Sell and 3 Hold. Therefore 50% are positive. ChemoCentryx had 12 analyst reports since September 3, 2015 according to SRatingsIntel. The stock of ChemoCentryx, Inc. (NASDAQ:CCXI) earned “Hold” rating by Cowen & Co on Tuesday, August 8. JMP Securities maintained ChemoCentryx, Inc. (NASDAQ:CCXI) rating on Thursday, August 10. JMP Securities has “Buy” rating and $1300 target. JP Morgan maintained ChemoCentryx, Inc. (NASDAQ:CCXI) rating on Tuesday, March 13. JP Morgan has “Overweight” rating and $16 target. JP Morgan downgraded ChemoCentryx, Inc. (NASDAQ:CCXI) rating on Tuesday, August 14. JP Morgan has “Neutral” rating and $15 target. Zacks downgraded the shares of CCXI in report on Monday, September 21 to “Sell” rating. On Tuesday, February 21 the stock rating was initiated by JMP Securities with “Mkt Outperform”. The stock of ChemoCentryx, Inc. (NASDAQ:CCXI) has “Buy” rating given on Monday, November 12 by Canaccord Genuity. Zacks downgraded the shares of CCXI in report on Thursday, September 3 to “Sell” rating.

Investors sentiment increased to 1.03 in Q2 2018. Its up 0.08, from 0.95 in 2018Q1. It improved, as 20 investors sold PAA shares while 94 reduced holdings. 35 funds opened positions while 82 raised stakes. 316.32 million shares or 0.69% less from 318.52 million shares in 2018Q1 were reported. Neuberger Berman Gp Ltd Limited Liability Company invested in 192,183 shares or 0.01% of the stock. North Star Mgmt accumulated 800 shares. Salem Investment Counselors holds 308 shares. Bank Of Montreal Can holds 0.17% or 8.77 million shares in its portfolio. Evergreen Capital Mgmt Limited Liability Co has invested 0.05% in Plains All American Pipeline, L.P. (NYSE:PAA). The Illinois-based Guggenheim Cap Limited Liability Company has invested 0% in Plains All American Pipeline, L.P. (NYSE:PAA). King Luther Cap Management reported 0% stake. Sumitomo Mitsui Trust invested in 0.01% or 399,000 shares. Bridges Mngmt has invested 0.03% in Plains All American Pipeline, L.P. (NYSE:PAA). Advisory Ser Net Ltd Company invested in 0% or 1,978 shares. Nuveen Asset Mgmt Limited Co stated it has 14,955 shares. Rocky Mountain Advisers Lc holds 244 shares or 0.02% of its portfolio. Tiaa Cref Inv Management Llc has invested 0.06% in Plains All American Pipeline, L.P. (NYSE:PAA). Fiduciary Fincl Of The Southwest Inc Tx invested 0.2% in Plains All American Pipeline, L.P. (NYSE:PAA). Rafferty Asset Mgmt Lc invested in 92,978 shares or 0.03% of the stock.

More important recent Plains All American Pipeline, L.P. (NYSE:PAA) news were published by: Globenewswire.com which released: “Research Report Identifies DXP Enterprises, Diebold Nixdorf, Fitbit, Nevro, Plains All American Pipeline, and Cara …” on November 12, 2018, also Fool.com published article titled: “A Texas-Sized Surge in Oil Production Will Hold Prices Down”, Businesswire.com published: “Plains All American Pipeline, LP and Plains GP Holdings Report Third-Quarter 2018 Results” on November 06, 2018. More interesting news about Plains All American Pipeline, L.P. (NYSE:PAA) was released by: Fool.com and their article: “These 3 Oil Stocks Got Clobbered in October (and at Least 1 Looks Like a Great Buy)” with publication date: November 09, 2018.

Salient Trust Company Lta, which manages about $863.11 million US Long portfolio, decreased its stake in Coca Cola Co (NYSE:KO) by 15,977 shares to 535,111 shares, valued at $23.47 million in 2018Q2, according to the filing. It also reduced its holding in Abbott Labs (NYSE:ABT) by 8,214 shares in the quarter, leaving it with 190,967 shares, and cut its stake in Apple Inc (NASDAQ:AAPL).

Since August 29, 2018, it had 0 insider purchases, and 1 insider sale for $279,063 activity.

Among 30 analysts covering Plains All American Pipeline LP (NYSE:PAA), 16 have Buy rating, 1 Sell and 13 Hold. Therefore 53% are positive. Plains All American Pipeline LP had 119 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was downgraded by Robert W. Baird to “Underperform” on Monday, February 8. Morgan Stanley upgraded it to “Buy” rating and $26.0 target in Tuesday, February 13 report. As per Monday, April 24, the company rating was maintained by Macquarie Research. SunTrust upgraded the stock to “Buy” rating in Monday, April 9 report. On Monday, May 22 the stock rating was upgraded by Raymond James to “Outperform”. As per Thursday, February 8, the company rating was maintained by RBC Capital Markets. The stock of Plains All American Pipeline, L.P. (NYSE:PAA) has “Buy” rating given on Tuesday, August 16 by Citigroup. Robert W. Baird maintained the shares of PAA in report on Wednesday, August 30 with “Hold” rating. The company was maintained on Friday, March 2 by UBS. Stifel Nicolaus maintained the stock with “Buy” rating in Thursday, August 6 report.

ChemoCentryx, Inc. (NASDAQ:CCXI) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *